Global Minimally Invasive Gastrointestinal Surgical Systems Market to Reach USD9.64 Billion by 2030

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The Global Minimally Invasive Gastrointestinal Surgical Systems Market size was valued at around USD6.63 billion in 2024 and is projected to reach USD9.64 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 6.43% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The rapidly increasing registration of GI diseases like colorectal cancer, GERD, hernia, & inflammatory bowel syndrome (IBS), i.e., owing to the unhealthy eating habits & changing lifestyles of people, is the prime aspect predicted to propel the industry’s expansion in the coming years.

It, in turn, is demonstrating a rise in the demand for Minimally Invasive Gastrointestinal Surgical Systems and making significant contributions to the market. Moreover, the growing elderly population, having higher chances of these illnesses, is amongst the prominent consumers of these systems, significantly stimulating the market growth. Also, the growing preference for robotic-assisted surgeries is a major key trend in the minimally invasive GI surgical systems market, driven by improved precision, faster recovery, minimal scarring, and ongoing technological enhancements.

Additionally, several factors are expected to restrain the growth of the Global Minimally Invasive Gastrointestinal Surgical Systems Market. These include an uncertain and often complex regulatory environment, the high costs associated with advanced surgical systems and procedures, and a shortage of adequately trained professionals to operate such technologies. Additionally, limited or inconsistent reimbursement policies for minimally invasive surgeries across various regions and prolonged patient waiting times in many healthcare systems further hinder market expansion.

Furthermore, rising complications in clinical decision-making, the immense burden on radiologists, and massive investments by the governments & private companies in R&D & healthcare infrastructure, alongside possibilities of promising results in minimally invasive surgeries, are the other aspects promoting the market growth, further states the research report, “Global Minimally Invasive Gastrointestinal Surgical Systems Market Analysis, 2025.”

Global Minimally Invasive Gastrointestinal Surgical Systems Market Segmentation Analysis

Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS) Hold Maximum Market Share

Based on product type, the market is further bifurcated into Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS), and surgical robotics. Amongst Endoscopes and endoscopy systems of Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS) is currently the most prominent product type that holds the largest market share. This dominance is attributed to relatively lower procedural costs and ongoing technological innovations such as capsule endoscopy, which support the effective diagnosis and treatment of GI disorders, particularly among the elderly. Conversely, surgical robotics product type is rapidly gaining traction due to advantages like improved precision, enhanced dexterity, and reduced risk of complications. These systems offer better visualization and control, overcoming the limitations of conventional endoscopy. Robotic surgery minimizes tissue damage, post-operative pain, and hospital readmissions, making it increasingly preferred for complex GI procedures. With rising demand for automation and workflow efficiency in healthcare, surgical robotics is poised to capture a growing share of the market in the coming years.

North America Leads the MISS Industry

North America holds the largest share in the Minimally Invasive Gastrointestinal Surgical Systems Market. This dominance is attributed to the increasing number of world-class medical facilities, massive investments in the healthcare sector by the governments of different countries to bring innovations in different therapeutics, and a high prevalence of chronic diseases, especially across countries like the US & Canada, augmenting the demand for these systems.

Besides, other factors like changing lifestyles, improper eating habits, limited physical activity, & easy availability & frequent intake of therapeutic drugs, resulting in the growing patient pool for various GI diseases, are also surging the demand for these systems across diverse healthcare facilities. The same aspect is also generating lucrative opportunities for the players to increase their production & distribution capacities to cater to the rising demands and make contributions to the overall market growth through 2030.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including B. Braun Melsungen AG, Conmed Corporation, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Stryker Corporation, TransEnterix, Inc., Boston Scientific Corporation, Cook Medical, Inc., Richard Wolf GmbH, Intuitive Surgical, Inc., Ambu A/S, Schölly Fiber Optic GmbH, Xenocor, Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), and Others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the regions?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across the regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?